Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Oct 2021. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4651602015 | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
4651603013 | Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Is a | Product containing lidocaine and metronidazole and sucralfate (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Is a | Product containing metronidazole in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Is a | Product containing lidocaine in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Has active ingredient | Metronidazole | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Has active ingredient | Sucralfate | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Has active ingredient | Lidocaine | true | Inferred relationship | Existential restriction modifier | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Is a | True | Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
Product containing precisely lidocaine hydrochloride 40 milligram/1 gram and metronidazole 10 milligram/1 gram and sucralfate 70 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | True | Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets